• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight

Race Oncology Ltd (RAC) is a specialty pharmaceutical company. Its business model is to pursue later stage drug assets, principally in the cancer field. Its important asset is a chemotherapy drug, called Bisantrene. Race Oncology is rediscovering Bisantrene.
View the full Corporate Spotlight arrow Created with Sketch.

director sees "extreme, untapped value" in company

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RAC
Chart
10:40 56 9.0K
10:40 Last post  EWexplorer Comments Created with Sketch.  56  Views Created with Sketch.  9.0K 
RAC 08:44 0 125
08:44 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  125 
RAC
Chemgenex aussie leukemia biotech acq $231 mil
02:41 1 283
02:41 Last post  biotechtrader73 Comments Created with Sketch.  1  Views Created with Sketch.  283 
RAC 12/11/18 4 641
12/11/18 Last post  EWexplorer Comments Created with Sketch.  4  Views Created with Sketch.  641 
RAC 12/11/18 0 203
12/11/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  203 
RAC
investing in tbe fast growing AML market.
12/11/18 3 649
12/11/18 Last post  optimistic punter Comments Created with Sketch.  3  Views Created with Sketch.  649 
RAC
Japanese sumitomo buys AML drug company.
12/11/18 0 199
12/11/18 Last post  biotechtrader73 Comments Created with Sketch.  0  Views Created with Sketch.  199 
RAC
Md anderson and Jazz AML collaboration.
12/11/18 0 154
12/11/18 Last post  biotechtrader73 Comments Created with Sketch.  0  Views Created with Sketch.  154 
RAC
75-80% chance of a deal here.
11/11/18 5 1.1K
11/11/18 Last post  supertramp Comments Created with Sketch.  5  Views Created with Sketch.  1.1K 
RAC
Partner deal will rocket stock.
09/11/18 18 2.6K
09/11/18 Last post  Meledath Comments Created with Sketch.  18  Views Created with Sketch.  2.6K 
RAC
research report
06/11/18 6 1.3K
06/11/18 Last post  Meledath Comments Created with Sketch.  6  Views Created with Sketch.  1.3K 
RAC
8 Million shares accumulated past 2 trading sessions 15-17.5c range
06/11/18 0 297
06/11/18 Last post  biotechtrader73 Comments Created with Sketch.  0  Views Created with Sketch.  297 
RAC
AML market $400 million growing to $3.5 billion in 5 years.
05/11/18 8 1.8K
05/11/18 Last post  biotechtrader73 Comments Created with Sketch.  8  Views Created with Sketch.  1.8K 
RAC
Reloaded
04/11/18 1 354
04/11/18 Last post  donteatme Comments Created with Sketch.  1  Views Created with Sketch.  354 
RAC 02/11/18 117 18K
02/11/18 Last post  Painkiller Comments Created with Sketch.  117  Views Created with Sketch.  18K 
RAC
Reason to be cheerful - part 3
02/11/18 0 193
02/11/18 Last post  supertramp Comments Created with Sketch.  0  Views Created with Sketch.  193 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

Replacement-Change in substantial holding notice
13 Nov 08:24
 
Change in substantial holding
12 Nov 16:16
 
Change of Director's Interest Notice-Dr William Garner
12 Nov 16:06
 
Response to ASX Price Query
01 Nov 13:39
 
Race appoints Biosynergy to pursue Bisantrene licensing
01 Nov 09:37
 
September 2018 Quarterly Report
26 Oct 08:17
 
View More arrow Created with Sketch.
(20min delay)
Last
13.5¢
Change
-0.01(6.90%)
Mkt cap $12.64M
Open High Low Value Volume
13.5¢ 13.5¢ 13.5¢ $30.46K 225.6K

Buyers (Bids)

No. Vol. Price($)
4 155550 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 68333 5
Last update - 11.33am 13/11/2018 (20 minute delay) ?
(live)
Last
13.0¢
  Change
-0.01 ( 10.3 %)
Open High   Low Volume
13.5¢ 13.5¢   13.0¢ 216226
Last updated 10.54am 13/11/2018 (live) ?
RAC (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.